IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Pre-Tax Income Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Pre-Tax Income
-kr177.8m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Pre-Tax Income
-kr468.3m
CAGR 3-Years
9%
CAGR 5-Years
-68%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Pre-Tax Income
kr292.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Pre-Tax Income
kr135m
CAGR 3-Years
36%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Pre-Tax Income
-kr25.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Pre-Tax Income
-kr198.4m
CAGR 3-Years
-42%
CAGR 5-Years
-22%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Pre-Tax Income?
Pre-Tax Income
-177.8m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Pre-Tax Income amounts to -177.8m SEK.

What is IRLAB Therapeutics AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-19%

Over the last year, the Pre-Tax Income growth was -57%. The average annual Pre-Tax Income growth rates for IRLAB Therapeutics AB have been -25% over the past three years , -19% over the past five years .

Back to Top